These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 7737354)
1. The function of inducible promoter systems in F9 embryonal carcinoma cells. Miller K; Rizzino A Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354 [TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of fibroblast growth factor-4 does not alter the growth or the differentiation of embryonal carcinoma cells. Miller K; Rizzino A Cell Growth Differ; 1996 Feb; 7(2):203-11. PubMed ID: 8822204 [TBL] [Abstract][Full Text] [Related]
3. The vimentin promoter as a tool to analyze the early events of retinoic acid-induced differentiation of cultured embryonal carcinoma cells. Benazzouz A; Duprey P Differentiation; 1999 Nov; 65(3):171-80. PubMed ID: 10631814 [TBL] [Abstract][Full Text] [Related]
4. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells. Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502 [TBL] [Abstract][Full Text] [Related]
5. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome. Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864 [TBL] [Abstract][Full Text] [Related]
6. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids. Härtig E; Cato AC Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882 [TBL] [Abstract][Full Text] [Related]
7. Cis-regulatory elements and transcription factors involved in the regulation of the transforming growth factor-beta 2 gene. Scholtz B; Kelly D; Rizzino A Mol Reprod Dev; 1995 Jun; 41(2):140-8. PubMed ID: 7654367 [TBL] [Abstract][Full Text] [Related]
8. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells. Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668 [TBL] [Abstract][Full Text] [Related]
9. Highly controlled heterologous gene expression through combined utilization of the tetracycline-repressible transactivator and the lac repressor. Hoshikawa Y; Amimoto K; Mizuguchi R; Hatakeyama M Anal Biochem; 1998 Aug; 261(2):211-8. PubMed ID: 9716424 [TBL] [Abstract][Full Text] [Related]
11. Rat tyrosine hydroxylase promoter directs tetracycline-inducible foreign gene expression in dopaminergic cell types. Gardaneh M; O'Malley KL Brain Res Mol Brain Res; 2004 Jul; 126(2):173-80. PubMed ID: 15249141 [TBL] [Abstract][Full Text] [Related]
12. Role of the transcription factor Sox-2 in the expression of the FGF-4 gene in embryonal carcinoma cells. Johnson LR; Lamb KA; Gao Q; Nowling TK; Rizzino A Mol Reprod Dev; 1998 Aug; 50(4):377-86. PubMed ID: 9669521 [TBL] [Abstract][Full Text] [Related]
13. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Liu HS; Scrable H; Villaret DB; Lieberman MA; Stambrook PJ Cancer Res; 1992 Feb; 52(4):983-9. PubMed ID: 1737361 [TBL] [Abstract][Full Text] [Related]
14. Tetracycline-inducible transgene expression mediated by a single AAV vector. Chtarto A; Bender HU; Hanemann CO; Kemp T; Lehtonen E; Levivier M; Brotchi J; Velu T; Tenenbaum L Gene Ther; 2003 Jan; 10(1):84-94. PubMed ID: 12525840 [TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. Yoshida Y; Hamada H Biochem Biophys Res Commun; 1997 Jan; 230(2):426-30. PubMed ID: 9016796 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the human MSX-1 promoter and an enhancer responsible for retinoic acid induction. Shen R; Chen Y; Huang L; Vitale E; Solursh M Cell Mol Biol Res; 1994; 40(4):297-312. PubMed ID: 7866431 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of inducible expression systems in transient transfection studies. Meyer-Ficca ML; Meyer RG; Kaiser H; Brack AR; Kandolf R; Küpper JH Anal Biochem; 2004 Nov; 334(1):9-19. PubMed ID: 15464949 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs. Kashanchi F; Sadaie MR; Brady JN Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142 [TBL] [Abstract][Full Text] [Related]
19. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. Freundlieb S; Schirra-Müller C; Bujard H J Gene Med; 1999; 1(1):4-12. PubMed ID: 10738580 [TBL] [Abstract][Full Text] [Related]
20. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Schuetz JD; Schuetz EG; Thottassery JV; Guzelian PS; Strom S; Sun D Mol Pharmacol; 1996 Jan; 49(1):63-72. PubMed ID: 8569713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]